Stock CTMX CYTOMX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts CytomX Therapeutics, Inc.

Equities

CTMX

US23284F1057

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.59 USD -0.62% Intraday chart for CytomX Therapeutics, Inc. -4.79% +2.58%
Apr. 22 JPMorgan Upgrades CytomX Therapeutics to Neutral From Underweight MT
Apr. 08 CytomX Therapeutics, Inc. Announces First Patient Dosed with CX-2051, A Conditionally Activated EpCAM-Directed ADC, in A Phase 1 Study in Patients with Advanced Solid Tumors CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Neutral

Neutral

Resistance 1.920 2.740 2.650
Spread/Res.-17.19%-41.97%-40.00%
Spread/Supp.+3.92%+48.60%+48.60%
Support 1.530 1.070 1.070

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. CTMX Stock
  4. Charts CytomX Therapeutics, Inc.